Form 4: Artivion SVP Sells Shares After Option Exercise

Artivion's SVP and General Counsel, Jean F. Holloway, executed pre-planned sales of common stock following the exercise of stock options.

Summary

• Jean F. Holloway, SVP and General Counsel of Artivion, Inc. (AORT), reported transactions involving the exercise of stock options and subsequent sale of common stock.
• On November 14, 2025, Holloway acquired 6,393 shares of common stock by exercising stock options at a price of $29.62 per share, totaling $189,360.06.
• Immediately following, 6,393 shares were sold at $45.00 per share, totaling $287,685.00.
• On November 17, 2025, Holloway acquired an additional 6,394 shares of common stock by exercising stock options at $29.62 per share, totaling $189,390.08.
• Concurrently, 6,394 shares were sold at $45.17 per share, totaling $288,709.98.
• All reported transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2025.
• Following these transactions, Holloway's direct beneficial ownership of Artivion common stock is 163,408 shares, and beneficial ownership of derivative securities (stock options) is 0.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this Form 4 reports routine, pre-planned insider transactions (option exercise and sale) and does not indicate any new fundamental information about the company's performance or prospects. The transactions were executed under a Rule 10b5-1 plan, which mitigates concerns about opportunistic trading.

Positives

• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, indicating they were not based on new, non-public information at the time of the trade.
• The insider realized a profit from the exercise of options and subsequent sale of shares, with sale prices significantly higher than the exercise price.

Negatives

• The insider's direct beneficial ownership of common stock remained at 163,408 shares after these transactions, indicating no net increase in direct equity exposure from these specific trades.

Future Outlook

This Form 4 filing is a report of past insider transactions and does not contain forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This is a routine insider transaction report (Form 4) for an executive exercising stock options and selling shares, which is a common occurrence in publicly traded companies. The transactions were pre-planned under a Rule 10b5-1 plan, which is a standard mechanism for insiders to trade company stock without being accused of trading on material non-public information.

Corporate Governance

Stakeholder Impact

• Shareholders: The sale of shares by an executive, even if pre-planned, slightly reduces the executive's direct equity stake, which some investors might view as a minor negative, though it's a common practice for executives to monetize vested options.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Recommendation

This Form 4 details routine, pre-planned insider transactions (option exercise and sale) by a senior executive. Such transactions, especially when conducted under a Rule 10b5-1 plan, are generally not considered indicative of a change in the company's fundamental outlook or a signal for significant price movement. Therefore, a 'hold' recommendation is appropriate as this filing alone does not provide new information to alter an existing investment thesis.

Keywords

Artivion, AORT, Insider Trading, Form 4, Stock Options, Rule 10b5-1, Executive Compensation, Share Sale, Beneficial Ownership